Kopran Ltd. (KOPRAN) 52 Week High Streak: Consecutive High Analysis

Kopran Ltd. 52 Week High Streak has now held for its second straight session, with the stock trading within 2% of its one-year high across the streak and moving 3.44% over that period. The latest price pattern places KOPRAN near its yearly peak, while the current move also shows the stock is not simply reacting to one isolated session. The latest Univest figures confirm the price pattern, but they do not establish a company-specific catalyst for the continued move.

As of 30 September 2026 at 9:52 AM IST, Kopran Ltd. share price was Rs 289 against the previous close of Rs 290.5, after opening at Rs 294 and touching a low of Rs 287.95. The stock traded up to Rs 295.9 in the session. Kopran Ltd. market cap stood at Rs 1,350.23 crore. For readers, the repeated near-high pattern is more relevant than a single-day move because it shows the stock has stayed close to its 52-week high across more than one session.

Kopran Ltd. 52 Week High Streak: Consecutive High Analysis

Metric	Value
Current Price	Rs 289
Previous Close	Rs 290.5
Today's Move	Rs -1.5 (-0.52%)
Open	Rs 294
High	Rs 295.9
Low	Rs 287.95
Market Capitalisation	Rs 1,350.23 crore

Kopran Ltd. (KOPRAN) traded at Rs 289 versus the previous close of Rs 290.5, a fall of 0.52%. The stock opened at Rs 294, reached a high of Rs 295.9 and touched a low of Rs 287.95.

Kopran Ltd. share price traded at Rs 289, down Rs 1.5 or 0.52% from the previous close of Rs 290.5. The stock opened at Rs 294, moved to a high of Rs 295.9 and a low of Rs 287.95, and was last trading near the lower half of that intraday range. That profile matters because it separates the broader Kopran Ltd. 52 Week High Streak from the day’s intraday movement. The company’s market cap was Rs 1,350.23 crore, keeping KOPRAN in the same broad valuation discussion that investors use for other mid-sized pharmaceutical names. For a stock near its yearly high, the day’s move does not change the larger streak narrative; it only adds session-level context to the repeated-high setup.

The key point is that KOPRAN continues to trade close to its 52-week high even when the day-to-day change is modest. That keeps the stock on the radar for readers following stocks at one year high today, but the current reading should be seen as part of the ongoing Kopran Ltd. 52 Week High Streak, not as a separate one-day breakout story.

What the Repeated 52-Week Highs Show

The repeated near-high pattern is the main story here. Kopran Ltd. has now traded within 2% of its 52-week high for a second straight session, and the cumulative move across that stretch is 3.44%. That is the cleanest way to read the Kopran Ltd. 52 Week High Streak: the stock is not just near its peak once, but has stayed in that zone across consecutive sessions. The latest data also confirms the price remains close to its one-year high rather than drifting back into a lower range.

This pattern does not, by itself, reveal why the stock has stayed near the top of its range. The latest Univest figures confirm the repeated-high setup, but they do not identify a company-specific trigger. That distinction matters for anyone searching for Kopran Ltd. stock news or trying to connect the move to a single event. In practical terms, the Kopran Ltd. 52 Week High Streak is best viewed as a price pattern first, with the reason for the persistence still unconfirmed.

For event-driven search intent, the stock is appearing in the same conversation as Kopran Ltd. New One Year High, Kopran Ltd. Back To Back 52 Week Highs and 52 Week High Stocks, even though the key fact remains unchanged: it is trading near, not above, its yearly peak.

Kopran Ltd. (KOPRAN) Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 1,350.23 crore
P/E Ratio	56.19x
P/B Ratio	2.62x
ROE	4.92%
ROCE	6.65%
EPS	Rs 5.17
Book Value Per Share	Rs 110.98
Dividend Yield	1.03%

Kopran Ltd. (KOPRAN) fundamental metrics show P/E 56.19x, P/B 2.62x, ROE 4.92%, ROCE 6.65%. These figures provide context only and are not a buy or sell signal.

Kopran Ltd. has a market capitalisation of Rs 1350.23 crore, which gives readers a sense of company size before judging valuation. On valuation, P/E at 56.19x, P/B at 2.62x should be read against the sector and peer benchmarks rather than as a standalone signal. Profitability is represented by ROE of 4.92% and ROCE of 6.65%, helping investors compare shareholder returns and capital efficiency. According to latest Univest data, additional metrics include EPS of Rs 5.17, book value per share of Rs 110.98, dividend yield of 1.03%, adding context to earnings, balance-sheet value and historical payout. Against the latest Univest same industry benchmark, these figures can be compared with benchmark median P/E of 28.2x, median ROE of 11.74%, median ROCE of 13.63%. These numbers explain the fundamental backdrop without converting the article into a buy or sell view.

Sector and Industry Context

Metric	Value
Sector	Healthcare
Industry	Pharmaceuticals & Drugs
Benchmark Scope	same industry
Company P/E Ratio	56.19x
Benchmark Median P/E	28.2x
Benchmark Average P/E	41.94x
Benchmark P/E Range	0x to 699.02x
Company P/B Ratio	2.62x
Benchmark Median P/B	2.89x
Company ROE	4.92%
Benchmark Median ROE	11.74%
Company ROCE	6.65%
Benchmark Median ROCE	13.63%
Company Market Capitalisation	Rs 1,350.23 crore
Benchmark Median Market Cap	Rs 773.14 crore

Kopran Ltd. (KOPRAN) is classified under sector: Healthcare and industry: Pharmaceuticals & Drugs.

Kopran Ltd. (KOPRAN) has a P/E ratio of 56.19x, which is above the benchmark median of 28.2x, a difference of +99.26%. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Kopran Ltd. (KOPRAN) has a ROE of 4.92%, which is below the benchmark median of 11.74%, a difference of -58.09%. Kopran Ltd. (KOPRAN) has a ROCE of 6.65%, which is below the benchmark median of 13.63%, a difference of -51.21%.

Track stocks reaching yearly peaks through the Univest 52-week-high screener. The peer table below provides the company-level comparison.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Fermenta Biotech Ltd.	FERMENTA	1,404.89	26.73	3.92	18.36	21.99
Amrutanjan Health Care Ltd.	AMRUTANJAN	1,460.42	27.11	3.9	16.62	22.46
Bharat Parenterals Ltd.	BPLPHARMA	1,473.12	0	4.18	-8.36	-1.82
Jagsonpal Pharmaceuticals Ltd.	JAGSNPHARM	1,549.67	34.08	6.73	18.19	22.69
Lincoln Pharmaceuticals Ltd.	LINCOLN	1,166.23	12.18	1.48	12.3	16.27

Kopran Ltd. (KOPRAN) has a P/E ratio of 56.19x compared with the displayed peer median of 26.73x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 4.92% compares with a peer median of 16.62% across the companies shown in the table. ROCE stood at 6.65% versus the displayed peer median of 21.99%, providing a capital-efficiency comparison. Kopran Ltd. (KOPRAN) has a market capitalisation of Rs 1,350.23 crore. Among the 5 peers shown, 4 have a larger market capitalisation.

Why Investors Are Watching Kopran Ltd.

• Kopran Ltd. 52 Week High Streak has held for a second straight session, keeping the stock near its yearly peak.
• The cumulative move across the streak is 3.44%, which is the main differentiator versus a one-session move.
• Kopran Ltd. share price is near a 52-week high, but the pattern does not confirm a company-specific catalyst.
• The stock trades at a P/E of 56.19, which is above the industry median in Pharmaceuticals & Drugs.
• The healthcare sector backdrop keeps Kopran Ltd. stock news relevant for investors tracking stocks hitting 52 week highs.

About Kopran Ltd.

Kopran Ltd. is listed in the Healthcare sector and operates in the Pharmaceuticals & Drugs industry. For investors following Kopran Ltd. share price today, the company’s current market capitalisation is Rs 1,350.23 crore. The latest financial markers show a P/E of 56.19, P/B of 2.62, ROE of 4.92%, ROCE of 6.65%, EPS of Rs 5.17 and book value of Rs 110.98. Dividend yield stands at 1.03%.

In stock market language, KOPRAN remains a name that can enter the discussion when markets screen for stocks at one year high today, stocks in news today and 52 week high stocks. The Kopran Ltd. 52 Week High Streak adds a short-term price pattern to that base picture, but the company still needs to be read through valuation and operating ratios rather than price alone.

Frequently Asked Questions

What does Kopran Ltd. 52 Week High Streak mean?

Ans. It means Kopran Ltd. has traded within 2% of its 52-week high for consecutive sessions. In this case, the stock has done so for a second straight session, which keeps it near its yearly peak.

How many sessions has KOPRAN traded near its 52-week high?

Ans. According to the latest Univest figures, KOPRAN has traded near its 52-week high for two consecutive sessions. That is the defining feature of the current Kopran Ltd. 52 Week High Streak.

What is the cumulative move across the streak?

Ans. The cumulative move across the streak is 3.44%. That figure is useful because it shows the broader price move across the repeated-high pattern, not just the latest session change.

Did Kopran Ltd. make a new 52-week high today?

Ans. No, the stock is trading near its 52-week high, not necessarily setting a new one today. The current pattern confirms proximity to the yearly peak rather than a new record.

Is a company-specific catalyst confirmed for the move?

Ans. No company-specific catalyst is confirmed by the latest Univest figures. The data confirms the price pattern, but it does not identify a particular event or announcement driving the repeated highs.

How is Kopran Ltd. valued versus peers?

Ans. Kopran Ltd. trades at a P/E of 56.19, which is above the industry median. Its P/B of 2.62 is slightly below the industry median, so the valuation picture is mixed across metrics.

What do the profitability ratios show?

Ans. ROE is 4.92% and ROCE is 6.65%, both below the industry medians shown in the sector snapshot. That suggests the stock’s valuation is not backed by standout return ratios at this point.

What should investors watch next in Kopran Ltd. stock news?

Ans. Investors can watch whether the stock continues to stay near its 52-week high, how the valuation compares with the peer set, and whether any company update explains the streak. The current pattern remains the main market signal.

Track Kopran Ltd. (KOPRAN) Share Price on Univest

Use Kopran Ltd. (KOPRAN) live share-price page, Univest 52-week-high screener, Univest market blogs to review live stock data, yearly-high lists and related market analysis.